Previous Article | Next Article 
Infection and Immunity, April 1999, p. 1547-1552, Vol. 67, No. 4
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Chemokine Secretion of Human Cells in Response to
Toxoplasma gondii Infection
Carolyn F.
Denney,1
Lars
Eckmann,1 and
Sharon L.
Reed1,2,*
Departments of
Medicine1 and
Pathology,2 University of California,
San Diego, San Diego, California 92103-8416
Received 12 August 1998/Returned for modification 16 September
1998/Accepted 5 January 1999
 |
ABSTRACT |
The ubiquitous protozoan parasite Toxoplasma gondii is
a major cause of morbidity and mortality in neonates and
immunocompromised hosts. Both acute invasion and reactivation of latent
infection result in an inflammatory reaction with lymphocytes,
macrophages, and neutrophils. The mechanisms responsible for triggering
the local host response to toxoplasmosis are not fully understood. Infection of monolayers of human HeLa epithelial cells and fibroblasts with T. gondii resulted in a marked increase in the
expression of interleukin-8 (IL-8)-specific mRNA and secretion of the
proinflammatory and chemoattractant cytokines interleukin-8 (IL-8),
GRO
, and MCP-1. Host cell invasion and lysis were required for this
response, as tachyzoite lysates alone had no effect on IL-8 secretion.
IL-8 release was dependent on the release of soluble host cell factors: IL-1
in HeLa cells and an additional mediator in fibroblasts. HT-29
epithelial cells, which lack IL-1
or another IL-8-inducing activity,
did not release IL-8 after infection, although they were efficiently
infected with T. gondii and increased IL-8 secretion in
response to added IL-1
. These data suggest that proinflammatory chemokine secretion is an important host cell response to toxoplasmosis and that the release of IL-1
and other mediators from lysed host cells is critical for this chemokine response.
 |
INTRODUCTION |
Toxoplasma gondii is one
of the most common parasitic infections worldwide, causing
life-threatening encephalitis in the immunocompromised host and
congenital infections in newborns. After patients ingest infective
tissue cysts or oocysts, released tachyzoites first invade and multiply
in intestinal epithelial cells (5), and then spread to
regional lymph nodes, leading to hematogenous and lymphatic
dissemination (2). Tachyzoites can invade any nucleated mammalian cell in an active process requiring release of the contents of specific parasite organelles followed by formation of a
parasitophorous vacuole and inhibition of phagosome-lysosome fusion
(23). Tachyzoites divide rapidly within the specialized
vacuole, resulting in lysis of the host cell, subsequent invasion of
adjacent cells, and dissemination. Early lesions are characterized by
necrotic areas containing tachyzoites surrounded by acute inflammation.
In latent infection, tachyzoites convert to slowly growing bradyzoites,
which can persist in tissues for life without eliciting an inflammatory
response. Upon profound deterioration in immunity, however,
reactivation of chronic (latent) infection can occur, eliciting an
inflammatory reaction consisting of lymphocytes, macrophages, and
neutrophils (2, 3, 24).
T lymphocytes, natural killer (NK) cells, and activated macrophages
have been shown to play important roles in resistance to T. gondii infection (13, 14, 26). In murine models,
depletion of both CD4+ and CD8+ T lymphocytes
causes reactivation of chronic infection (12). NK cells are
also critical, as SCID mice, without functional T cells, survive acute
T. gondii infection for at least 2 weeks (15). NK
cells are capable of lysing parasite-infected cells and releasing
cytokines, a key effector mechanism in controlling acute toxoplasmosis
(14, 15, 29). Gamma interferon (IFN-
) activation of
macrophages is particularly important, as infection is uniformly fatal
in IFN-
knockout mice (27, 30). Both interleukin-12 (IL-12) and tumor necrosis factor alpha (TNF-
) act synergistically to induce IFN-
release, which limits parasite replication (11, 17, 27).
In addition to the resistance conferred by macrophages and T cells,
neutrophils also play a role in host resistance to T. gondii. Neutrophils can phagocytose and kill opsonized
Toxoplasma (32). In vivo support comes from the
finding that mice deficient in inducible nitric oxide synthase (iNOS)
succumbed to acute infection following depletion of neutrophils
(28). Thus, it appears that neutrophils contribute to acute
resistance against this parasite and might account for the ability of
iNOS knockout mice to control infection in the apparent absence of
macrophage killing function. Neutrophils might scavenge infected
cells, secrete toxic products, or produce chemokines required for the
recruitment of other effector cell populations (18).
Chemokines are a group of chemotactic polypeptides that are key
mediators of leukocyte activation and chemotaxis (1, 20). They are divided into groups of related families based on the arrangement of cysteine residues in their amino-terminal domain (4, 22). The C-X-C or
-chemokines, of which IL-8 is a
prototype, are primarily involved in the recruitment and activation of
neutrophils, although they may attract other leukocyte populations
(20). The C-C or
-chemokines (e.g., MCP-1) attract
different leukocyte subsets, including monocytes, macrophages, and T
cells (20). Because chemokines are important
chemoattractants for neutrophils, macrophages, and T cells, which
accumulate at the site of T. gondii infection, the present
study investigated the potential role of chemokines in mediating the
initial inflammatory response after acute T. gondii infection.
 |
MATERIALS AND METHODS |
Human cell lines.
The human colon adenocarcinoma
cell line HT-29 (ATCC HTB 38) and HeLa cervix epithelioid carcinoma
cells were obtained from the American Type Culture Collection
(Rockville, Md.) and were grown in Dulbecco's modified Eagle's medium
(DME, Irvine Scientific, Santa Ana, Calif.) supplemented with 10%
fetal calf serum (FCS; Sigma Chemical, St. Louis, Mo.) and 1%
penicillin-streptomycin-amphotericin B. Primary human foreskin
fibroblasts (from Mark Sawyer [University of California, San Diego]
or the American Type Culture Collection) were subcultured initially in
DME supplemented with 10% FCS and 1%
penicillin-streptomycin-amphotericin B at 37°C in 5%
CO2-95% air until confluent and maintained subsequently
with 2% FCS.
T. gondii tachyzoites.
T. gondii RH
tachyzoites were cultured in primary human foreskin fibroblast cultures
as described above in 2% FCS. Following cell lysis, T. gondii tachyzoites were harvested, centrifuged, washed twice with
phosphate-buffered saline (PBS), and resuspended in DME prior to
inoculation into cell cultures. Direct cell counts were determined in a hemocytometer.
Infection protocol.
Epithelial cells or fibroblasts were
seeded into 24-well plates (Corning Costar Corp., Cambridge, Mass.) and
grown to confluence. Fibroblasts required 3 to 7 days to reach 100%
confluence, whereas HeLa and HT-29 cells became confluent within 1 to 3 days. When monolayers were confluent, the medium was removed and
102 to 106 washed tachyzoites in DME
supplemented with 2% FCS and antibiotics were added. Controls included
wells in which DME alone was added to the cell cultures following
removal of the original medium. Cultures were incubated at 37°C for 6 to 72 h. Supernatants were removed, filtered through a
0.22-µm-pore-size filter to remove tachyzoites and debris, and stored
at
80°C prior to performance of the assays.
The number of viable cells in the monolayer was determined by washing
the cultures three times with PBS and detaching the monolayer with
trypsin-EDTA. Cells were centrifuged at 1,000 rpm for 10 min and
resuspended in 0.25% trypan blue in PBS, and the viable cells were
counted. To confirm infection of HT-29 cells, infected monolayers were
washed three times with PBS and detached with trypsin-EDTA. Host cells
were disrupted by passage through a 27-gauge needle, and the number of
released tachyzoites was determined by phase-contrast microscopy.
Cytokine assays.
Cytokine concentrations in culture
supernatants and cell lysates were determined by enzyme-linked
immunosorbent assay (ELISA) using the following pairs of capturing and
detecting antibodies: goat anti-human IL-8 (R&D Systems Inc.,
Minneapolis, Minn.) and rabbit anti-human IL-8 (Endogen, Inc.,
Cambridge, Mass.); goat anti-human GRO
(R&D Systems) and monoclonal
mouse anti-human GRO
(R&D Systems); goat anti-human MCP-1 (R&D
Systems) and rabbit anti-human MCP-1 (Genzyme Corp., Boston, Mass.);
goat anti-human ENA-78 (R&D Systems) and monoclonal mouse anti-human
ENA-78 (R&D Systems); and goat anti-human IL-1
(R&D Systems) and
monoclonal mouse anti-human IL-1
(Genzyme Corp.). Peroxidase-labeled
goat anti-rabbit immunoglobulin G (IgG) and light chains (Biosource International, Camarillo, Calif.) or peroxidase-labeled goat anti-mouse IgG and light chains (Biosource International) were used as secondary antibodies. Sensitivities of the ELISAs were 50 pg/ml for IL-8, GRO
and MCP-1, 100 pg/ml for ENA-78, and 10 pg/ml for IL-1
.
RNA extraction and reverse transcription-PCR (RT-PCR) analysis of
IL-8 mRNA levels.
Tissue culture flasks (25 cm2;
Corning Costar Corp.) were seeded with HeLa or HT-29 cells and grown to
confluence. Washed tachyzoites (5 × 105) were then
inoculated into each flask, and cultures were incubated for 8, 24, or
48 h. Uninfected monolayers were used as controls. Total cellular
RNA was extracted by an acid guanidium thiocyanate-phenol-chloroform method (6). RNA was quantified by determining the optical
density at 260 nm, and the integrity was confirmed by gel
electrophoresis. Reverse transcription, PCR amplification, and
quantitation of IL-8 mRNA were performed as described previously
(16), using internal RNA standards. For each experiment, 1 µg of total cellular RNA was used. PCR products were electrophoresed
and visualized by ethidium bromide staining, and photographs of the
gels were taken with Polaroid 665 film. Band intensities were
quantified by densitometry (GS-670 imaging densitometer; Bio-Rad
Instruments, Hercules, Calif.), and the number of IL-8 transcripts was
derived by determining the point at which the number of standard
RNA transcripts was equivalent to the number of cellular target
RNA transcripts (16).
Preparation of cell lysates and supernatants.
Tachyzoites
were released from host cell monolayers by using a 27-gauge needle,
separated from cell debris by filtration through 3.0-µm-pore-size
Nuclepore filters, and resuspended in PBS. Tachyzoite lysates were
prepared by three freeze-thaw cycles followed by sonication for 15 to
20 s in a Fisher Sonic Dismembrater (model 300).
Supernatants of uninfected monolayers were collected 48 h after
fresh medium was added to the confluent monolayers. Supernatants
of
infected monolayers were collected after the monolayers were
infected
with 5 × 10
5 tachyzoites/25-cm
2 flask,
incubated for 48 h, and filtered to remove live tachyzoites
prior
to inoculation on fresh
monolayers.
Lysates of uninfected monolayers were prepared by growing fibroblasts
or HeLa cells to confluence in 25-cm
2 tissue culture
flasks. Cell monolayers were washed with PBS,
removed by scraping,
suspended in fresh medium, and subsequently
sonicated on ice for 5 s. The lysates were added to uninfected
monolayers in an amount
equivalent to approximately twice the
number of cells as the monolayer
to which they were added. Lysates
of infected monolayers were prepared
in a similar manner after
the monolayers were infected with 5 × 10
5 tachyzoites/flask and incubated for 48
h.
To test for an IL-8-inducing activity released by extracellular
tachyzoites, purified tachyzoites were incubated at a concentration
of
10
6/ml of DME for 4 h at 37°C, and the tachyzoites
were removed by
filtration. The supernatants were then added to fresh
fibroblast
monolayers in 24-well plates and incubated for 24 h,
and secreted
IL-8 was detected by ELISA. Controls included fibroblasts
incubated
with DME alone or stimulated with IL-1

(20 ng/ml).
 |
RESULTS |
T. gondii infection induces the release of chemokines
by human fibroblasts and HeLa epithelial cells.
To characterize
the factors which may elicit the acute inflammatory infiltrate detected
in acute and reactivation toxoplasmosis (3, 24), we
evaluated the release of chemokines, which are potent chemoattractants
and activators of neutrophils and macrophages. We first assessed the
chemokine response in a primary human fibroblast cell line, which has
not been transformed for long-term culture propagation. Monolayers of
primary human fibroblasts were infected with T. gondii, and
secretion of the prototypic neutrophil chemoattractant IL-8 was
determined by ELISA. As shown in Fig. 1A,
T. gondii-infected fibroblasts secreted >900-fold more IL-8
than uninfected controls. A small increase in IL-8 secretion was first
observed at 8 h postinfection, and maximal IL-8 production was
seen in the period between 24 and 48 h after infection. Although
IL-8 levels continued to increase over the 72-h period of the
experiment, absolute levels of IL-8 production decreased in the 48- to
72-h period compared to the 24- to 48-h period after infection. This
decrease probably was not due to decreased IL-8 production per cell but
rather was related to a decrease in the numbers of viable fibroblasts
remaining in the culture at 48 and 72 h after infection due to
T. gondii-induced cell lysis (Fig. 1B). Both the magnitude
of the IL-8 response (Fig. 2) and the
extent of cell lysis (data not shown) were related to the size of the
initial inoculum.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 1.
Increased IL-8 secretion by human fibroblasts in
response to infection with T. gondii. (A) IL-8 secretion.
Fibroblast monolayers in 24-well plates were infected with 2.5 × 105 tachyzoites/well ( ) or left uninfected for controls
( ). Supernatants were collected at the indicated times, and IL-8
concentrations were determined by ELISA. The increase in IL-8 secretion
following T. gondii infection was significant at 48 and
72 h (P < 0.05, Student's paired t
test). (B) Viable cell counts. The number of viable cells in the
fibroblast monolayers was determined by trypan blue dye exclusion
following detachment of the cells with trypsin-EDTA. Values are
reported as the percentage of uninfected monolayers at each time point
(mean ± standard error of the mean; n = 4 to
6).
|
|

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Relationship of T. gondii inoculum size and
cumulative IL-8 secretion. Fibroblast monolayers in 24-well plates were
infected with 103 to 106 tachyzoite/well and
incubated for 48 h. IL-8 concentrations are shown as means ± standard errors of the means (n = 4).
|
|
Since
T. gondii also invades epithelial cells in vivo and in
vitro (
5,
10,
19), we next determined the cytokine response
of infected HeLa epithelial cells. These cells are readily infected
by
T. gondii, and they have been previously shown to have
well-defined
cytokine responses to infection with other invasive
pathogens
(
7,
8,
25). Infection of HeLa cells with
T. gondii also
markedly increased IL-8 production >60-fold at
48 h postinfection
(Fig.
3). Similar
to fibroblasts, maximal IL-8 secretion by HeLa
cells in response to
T. gondii infection was observed at higher
inocula
(10
6 tachyzoites/well), which also resulted in significant
cell lysis
(Fig.
3). Moreover, at a lower inoculum (2.5 × 10
5), maximal IL-8 secretion was not observed until 72 h postinfection,
indicating that the time of maximal IL-8 secretion is
dependent
on the initial
T. gondii inoculum.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 3.
Time dependence of maximal IL-8 secretion on the
T. gondii inoculum. HeLa cell monolayers in 24-well plates
were infected with 2.5 × 105 ( ) or 1 × 106 ( ) tachyzoites/well, or left uninfected as controls
( ), and incubated for 8 to 72 h. (A) IL-8 secretion. IL-8
concentrations were determined by ELISA. Data points represent
means ± standard errors of the means (n = 4).
IL-8 secretion at 48 and 72 h was significantly increased above
controls (P < 0.02, Student's paired t
test). (B) Viable cell counts. The number of viable cells in the
monolayers was determined by trypan blue dye exclusion following
detachment of the cells with trypsin-EDTA. Values represent the
means ± standard errors of the means of three or more
determinations.
|
|
To investigate whether infection with
T. gondii elicits
secretion of cytokines other than IL-8, we determined the levels of
three additional chemokines, GRO

, MCP-1, and ENA-78, in supernatants
from infected and control cultures. As shown in Table
1, the
GRO

response was very similar
to that observed with IL-8; at
48 h after infection, infected HeLa
cells secreted >100-fold-higher
levels and fibroblasts secreted
>30-fold-higher levels of GRO
compared to uninfected controls.
Infected fibroblasts also released
significantly higher levels of MCP-1
compared with uninfected
controls. Uninfected HeLa cells had
significant baseline production
of MCP-1, which doubled with infection
by
T. gondii. Neither cell
line produced detectable levels
of ENA-78 before or after infection
with
T. gondii.
T. gondii infection of HeLa epithelial cells increases
IL-8 mRNA expression.
We next investigated whether increased IL-8
secretion after T. gondii infection was paralleled by
increased IL-8 mRNA expression. Infection of HeLa cells with T. gondii increased IL-8 mRNA levels at 24 and 48 h after
infection, as determined by RT-PCR analysis (Fig.
4). This finding was confirmed by
quantitative RT-PCR using internal RNA standards, which showed a
50-fold increase in IL-8 mRNA levels at 24 h after infection
(8 × 104 transcripts/µg of total RNA after
infection versus 1.6 × 103 transcripts/µg of RNA in
controls). In contrast to IL-8, levels of the mRNA for
-actin were
not affected by T. gondii infection of HeLa cells (Fig. 4).

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 4.
Increased IL-8 mRNA expression after T. gondii infection of HeLa cells. Monolayers of HeLa cells in
25-cm2 tissue culture flasks were infected with 5 × 105 T. gondii tachyzoites and incubated for the
indicated periods. Total RNA was extracted, and levels of IL-8 and
-actin transcripts were determined by RT-PCR. Twenty microliters of
each PCR mixture was electrophoresed and stained with ethidium bromide.
As a negative control, RNA was omitted from reverse transcription and
PCR amplification (No RNA).
|
|
IL-8 response to T. gondii infection requires live
tachyzoites.
Increased cytokine secretion has also been reported
after in vitro infection of epithelial cells by fungi and protozoa
other than T. gondii, including Entamoeba
histolytica and Aspergillus fumigatus (31,
33). For these pathogens, soluble products were found to be
important for stimulating IL-8 release. Lysates of E. histolytica stimulated IL-8 secretion from human colonic epithelial cells in the absence of cell-cell contact (33),
while released serine proteases of A. fumigatus induced the
production of IL-8, IL-6, and MCP-1 in epithelial cells
(31). Therefore, we investigated the ability of soluble
cellular components of Toxoplasma to stimulate IL-8
secretion. Monolayers of fibroblasts were either infected with 5 × 105 viable tachyzoites/well or exposed to an
equivalent number of sonicated tachyzoites. After 24 to 48 h
of incubation, infection with live tachyzoites resulted in
a 25- to 100-fold increase in IL-8 secretion (Fig. 1). In contrast,
when the same number of sonicated tachyzoites were added to the
fibroblast cultures, IL-8 secretion did not increase (data not shown).
To rule out the possibility of active secretion of an IL-8-inducing
activity by extracellular tachyzoites themselves, tachyzoites
were incubated for 4 h at a concentration of 106/ml of
DME, which is at least 1,000-fold higher than would be seen
extracellularly in 24-h cultures. When the supernatants were added to
fresh fibroblast monolayers for 24 h, a small increase in IL-8 was
detected (0.56 ng/ml versus <0.05 ng/ml in unstimulated controls).
This value was less than 10% of the stimulation induced by infection
with the same number of live tachyzoites at 24 h (mean of 6.0 ng/ml). Therefore, it appears that infection by intact, viable
tachyzoites is the primary factor in eliciting an increase in IL-8 production.
IL-1
is the principal mediator of T. gondii-induced
IL-8 secretion in HeLa cells but not in fibroblasts.
Since maximal
IL-8 secretion in response to T. gondii infection was
observed at inocula which caused substantial lysis of fibroblasts and
HeLa cells, we hypothesized that components of these host cells
released during lysis may mediate the IL-8 response. Such a mechanism
was previously described for infection with two other cytolytic
pathogens, E. histolytica and Chlamydia
trachomatis, where IL-1
was identified as the crucial mediator
of increased cytokine production after infection (8, 25). To
test a role of IL-1
in mediating the T. gondii-induced
IL-8 response, monolayers of fibroblasts and HeLa cells were infected
with T. gondii in the presence or absence of antibodies
against IL-1
to block any potential IL-1
activity that may be
released during the infection. As shown in Table
2, anti-IL-1
antibodies completely
(>98%) blocked the IL-8 response of HeLa cells to T. gondii infection. In contrast, increased IL-8 production by
T. gondii-infected fibroblasts was decreased by only 40% by
addition of antibodies against IL-1
, although the same antibodies
fully blocked IL-1
-induced IL-8 secretion by these cells.
Furthermore, no additional inhibition was achieved with higher
concentrations of anti-IL-1
antibodies (up to 100 µg/ml).
To confirm a role of IL-1

in mediating the IL-8 response to
T. gondii infection, we directly determined IL-1

levels in the
supernatants of infected HeLa cells and fibroblasts.
T. gondii infection of HeLa cells increased IL-1

levels in the
supernatants
at 48 h after infection in a dose-dependent manner.
Thus, after
infection with 2.5 × 10
5, 5 × 10
5, and 10
6 tachyzoites/well, IL-1

levels
were 39 ± 12, 95 ± 35, and 197
± 24 pg/ml,
respectively, whereas uninfected control cells had
<10 pg/ml in the
supernatants. These data support a key role for
IL-1

in mediating
T. gondii-induced IL-8 secretion in HeLa cells.
In contrast
to HeLa cells, IL-1

appeared to play a minor role
in the induction
of IL-8 by
T. gondii in fibroblasts (Table
2).
Consistent
with this finding, only low levels of IL-1

(<10 pg/ml)
were
detected in supernatants of
T. gondii-infected
fibroblasts.
Release of an IL-8-inducing activity from T. gondii-infected fibroblasts.
Because IL-1
release played
a minor role in mediating the IL-8 response to T. gondii
infection in fibroblasts, we next determined whether infected
fibroblasts released an IL-8-inducing activity other than IL-1
or if
the IL-8 response of these cells was a direct response to infection.
For these experiments, 48-h supernatants from infected and control
cells were tested for the ability to induce IL-8 secretion in cultures
of uninfected fibroblasts (test cultures). Since the 48-h supernatants
already contained substantial levels of IL-8 (Fig. 1), which could
confound the assessment of additional IL-8 production, we stimulated
the test cultures with 48-h supernatants for only a short period (2 h),
sufficient to activate increased IL-8 expression (25). The
supernatants were then removed by repeated washing, fresh medium was
added, and IL-8 secretion by the test cultures was determined after an
additional 6 h of incubation. This approach allowed us to assess
IL-8 production by fibroblasts in the absence of any IL-8 from the
original 48-h supernatants (the latter was confirmed by the observation
that <100 pg of IL-8/ml was detected in the final washes used to
remove the original supernatants). Using this approach, we found that 48-h supernatants from uninfected control fibroblasts had no
significant effect on IL-8 secretion, whereas supernatants from
T. gondii-infected fibroblasts increased IL-8 secretion by
the test cultures >10-fold (Table 3).
The IL-8-inducing activity present in the supernatants from infected
fibroblasts could not be blocked by addition of antibodies against
IL-1
or TNF-
and was blocked by only approximately 30% after
addition of antibodies to IL-1
(Table 3).
To determine whether a preexisting activity was present in fibroblasts
or if the IL-8-inducing activity was induced during
the course of
infection, lysates of uninfected and infected fibroblasts
were added to
fresh fibroblast monolayers. Greater than 5-fold
stimulation of IL-8
secretion could be induced by uninfected fibroblast
lysates, while
>10-fold induction was detected after addition
of lysates from
infected cells. As with supernatants, the activity
was not blocked by
antibodies to IL-1

or TNF-

but was partially
inhibited by
antibodies to IL-1

(although not to a statistically
significant
extent) (Table
3). No additional effect was seen
when all three
antibodies were used in combination. These results
suggest that a
bioactive factor other than IL-1

, IL-1

, or TNF-
was
upregulated and released from fibroblasts during infection
with
T. gondii and was important for stimulating IL-8
production.
T. gondii infection of HT-29 epithelial cells that do
not contain an IL-8-inducing activity has no effect on IL-8
secretion.
The studies in HeLa cells and fibroblasts suggested
that IL-1
or another IL-8-inducing activity is an important mediator of the IL-8 response to T. gondii infection. Based on these
findings, we hypothesized that cells that do not express IL-1
or
another IL-8-inducing activity might not respond to T. gondii infection with increased IL-8 secretion. To test this, we
used HT-29 human intestinal epithelial cells which were shown
previously to neither express IL-1
mRNA nor contain preformed
IL-1
or another IL-8-inducing activity (8, 16).
Monolayers of HT-29 cells were infected efficiently by T. gondii, as they released as many tachyzoites as, or even more
than, HeLa cells when incubated with 2.5 × 105
tachyzoites/well for 48 h (data not shown). Furthermore, 80 to 100% of the HT-29 monolayer was lysed within 72 h of infection (at inocula of 5 × 104 to 1 × 106
tachyzoites/well). Nevertheless, T. gondii infection had no
effect on IL-8 secretion by HT-29 cells at 24 to 72 h after
infection (354 ± 38 pg of IL-8/ml from T. gondii-infected HT-29 cells versus 393 ± 21 pg/ml from
uninfected controls; n = 4). Furthermore, IL-8 mRNA
levels in HT-29 cells were not increased by infection with T. gondii (data not shown). The lack of an IL-8 response was not due
to an inability of HT-29 cells to upregulate IL-8 secretion since
stimulation of control HT-29 cells with IL-1
or TNF-
resulted in
an approximately 200-fold increase in IL-8 production. Furthermore,
T. gondii infection was not inhibitory for IL-8 secretion of
HT-29 cells since infected and control cells increased IL-8 production
to the same extent after IL-1
and TNF-
stimulation. HT-29 cells
also did not secrete increased levels of MCP-1, GRO
, or ENA-78 in
response to T. gondii infection. Thus, despite efficient
infection of HT-29 cells with resultant cell lysis, T. gondii infection failed to elicit a chemokine response from these
cells that lack IL-1
or another IL-8-inducing activity.
 |
DISCUSSION |
Acute toxoplasmosis causes host cell lysis and an
inflammatory infiltrate consisting of lymphocytes, macrophages, and
neutrophils. A similar host response occurs when latent infection is
reactivated in immunocompromised patients with impaired cellular
immunity, particularly in patients with AIDS. We have shown that one
signal for the observed cellular infiltrate after T. gondii
infection may be the release of proinflammatory chemokines from
infected cells. Infection of primary fibroblasts, as well as
transformed epithelial cell lines, with T. gondii stimulates
secretion of the proinflammatory chemokines IL-8, GRO
, and MCP-1.
Secretion of IL-8 by host cells is associated with increased IL-8 mRNA
expression. The chemokine response is dependent on invasion by live
tachyzoites and subsequent host cell lysis. Furthermore, supernatants
or lysates from T. gondii-infected fibroblasts could elicit
significant IL-8 secretion when added to uninfected fibroblasts, and
IL-1
release played a crucial role in mediating the IL-8 response to
infection in HeLa cells.
The release of chemokines may contribute to the inflammatory infiltrate
that accompanies acute or reactivation toxoplasmosis. IL-8 and GRO
are both chemoattractants for neutrophils (20), which
accumulate at the site of acute T. gondii infection
(24). In vitro studies have shown that human neutrophils
inhibit T. gondii replication (32). The early
pathology of T. gondii infection in mice mimics human
disease with recruitment of neutrophils (5, 19, 27).
Neutrophil depletion by the administration of antigranulocyte antibody
markedly diminished early resistance of mice to Toxoplasma infection (28). In addition, mice with defective macrophage function from knockouts of iNOS were able to survive acute, but not
persistent, infection as long as their neutrophils were intact (28), suggesting that neutrophils contribute to acute
resistance to T. gondii infection.
Increased cytokine secretion in response to infection has been reported
for invasive pathogens other than T. gondii, including enteroinvasive bacteria (7, 16), E. histolytica
(8), Cryptosporidium parvum (21), and
Chlamydia sp. (25). Two distinct time courses of
cytokine responses are seen following infection with these pathogens.
Infection with invasive enteric bacteria (e.g., Salmonella spp. or enteroinvasive E. coli) evoked a rapid (within 2 to
3 h) and transient (lasting 4 to 10 h) expression and
secretion of C-X-C chemokines such as IL-8 (7, 16). Although
E. histolytica does not actually invade cells, it does
result in rapid host cell lysis with IL-8 secretion detectable within 2 to 4 h and maximum release by 4 to 8 h (8). In
contrast, the first detectable IL-8 was not noted until 8 h
following infection with T. gondii and failed to reach
maximum release until 48 to 72 h. Similarly, upregulated
expression and secretion of IL-8 were first detected 16 to 24 h
after C. parvum infection of epithelial cells
(21), while Chlamydia infection of epithelial
cells required at least 48 h to cause a detectable IL-8 response
(25). Slow inducers of a host proinflammatory cytokine
response, such as T. gondii, C. parvum, and
Chlamydia, induce little cytoskeletal changes in the host
cells during invasion and require a prolonged period of intracellular
development before lysing the host cell. In contrast, the rapid
cytokine inducers, enteroinvasive E. coli and
Salmonella, elicit extensive membrane ruffling and actin
redistribution in host cells (9), while E. histolytica rapidly lyses and disrupts host cells (8).
Cytokine release by host cells following T. gondii infection
appeared to require at least three steps: invasion by live tachyzoites, tachyzoite multiplication resulting in cell lysis, and a
paracrine-acting factor in host cells that can be released upon lysis.
In HeLa epithelial cells, upregulation of IL-8 production in uninfected neighboring cells is dependent on IL-1
release from lysed cells. Similarly, lysis of cells by E. histolytica also evoked an
IL-1
-dependent release of IL-8 (8), although
non-IL-1
-dependent mechanisms of IL-8 induction also exist
(33). Thus, amplification of IL-8 release by IL-1
may be
a conserved mechanism of host cell response to infection by lytic
pathogens. An additional host cell factor appears to upregulate IL-8
production in fibroblasts. Only a relatively small fraction of the IL-8
response of fibroblasts could be inhibited by antibodies to IL-1
,
and no inhibition occurred with antibodies to IL-1
or TNF-
,
other cytokines which can elicit IL-8 secretion (1).
HT-29 cells, a colonic cell line which lacks preformed IL-1
or other
IL-8-inducing activities (8, 16), failed to induce an IL-8
response after infection with T. gondii. Nevertheless, HT-29
cells secrete IL-8 upon stimulation with exogenous IL-1
and TNF-
,
demonstrating that this cell line is not deficient in inducible IL-8
production (6). In addition, HT-29 cells were not resistant
to infection by T. gondii, based on cell lysis studies and
enumeration of intracellular tachyzoites.
These studies may shed light on the host inflammatory response and
latency in T. gondii infection. Cell invasion or the
intracellular presence of T. gondii alone is not sufficient
to elicit an inflammatory cytokine response. Maximal IL-8 production in
HeLa cells and fibroblasts was delayed for >24 h until significant
cell lysis occurred. Slowly dividing bradyzoites would not cause cell
lysis and thus the subsequent release of factors such as IL-1
to
stimulate secretion of IL-8 by uninfected neighboring cells. In
addition, certain host cells, such as HT-29, can be effectively
infected by T. gondii, but infection elicits no inflammatory
cytokine response because they lack appropriate paracrine factors.
Induction of the host inflammatory response and the development of
latent infection are likely to be multifactorial, but these studies
suggest that release of IL-1
and other mediators from lysed host
cells is critical to elicit proinflammatory chemokine secretion and
provides an important signaling system to initiate the host
inflammatory response to active T. gondii infection.
 |
ACKNOWLEDGMENTS |
This work was supported in part by grants from the
University of California Universitywide AIDS Research Program (S.L.R.), the UCSD Academic Senate, the UCSD Center for AIDS Research (NIAID 5 P30 AI36214), the National Institutes of Health (AI41903), and the
Crohns and Colitis Foundation of America (L.E.).
We thank Jennifer Smith and Scott Herdman for their expert assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Infectious Diseases, UCSD Medical Center, 200 W. Arbor Dr., San Diego, CA 92103-8416. Phone: (619) 543-6146. Fax: (619) 543-6614. E-mail: slreed{at}popmail.ucsd.edu.
Editor:
J. M. Mansfield
 |
REFERENCES |
| 1.
|
Baggiolini, M.,
B. Dewald, and B. Moser.
1994.
Interleukin-8 and related chemotactic cytokines CXC and CC chemokines.
Adv. Immunol.
55:97-179[Medline].
|
| 2.
|
Bertoli, F.,
M. Espino,
J. R. Arosemena,
J. L. Fishback, and J. K. Frenkel.
1995.
A spectrum in the pathology of toxoplasmosis in patients with AIDS.
Arch. Pathol. Lab. Med.
119:214-224[Medline].
|
| 3.
|
Carrazana, E. J.,
E. Rossitch, and M. A. Samuels.
1989.
Cerebral toxoplasmosis in the acquired immune deficiency syndrome.
Clin. Neurol. Neurosurg.
91:291-299[Medline].
|
| 4.
|
Curfs, J. H. A. J.,
J. F. G. M. Meis, and J. A. A. Hoogkamp-Korstanje.
1997.
A primer on cytokines: sources, receptors, effects, and inducers.
Clin. Microbiol. Rev.
10:742-780[Abstract].
|
| 5.
|
Dupey, J. P.,
C. A. Speer,
S. K. Shen,
O. C. H. Kwok, and J. A. Blixt.
1997.
Oocyst-induced murine toxoplasmosis: life cycle, pathogenicity, and stage conversion in mice fed Toxoplasma gondii oocysts.
J. Parasitol.
83:870-882[Medline].
|
| 6.
|
Eckmann, L.,
H. C. Jung,
C. Schurer-Maly,
A. Panja,
E. Morzycka-Wroblewska, and M. F. Kagnoff.
1993.
Differential cytokine expression by human intestinal epithelial cells: regulated expression of interleukin-8.
Gastroenterology
105:1689-1697[Medline].
|
| 7.
|
Eckmann, L.,
M. F. Kagnoff, and J. Fierer.
1993.
Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry.
Infect. Immun.
61:4569-4574[Abstract/Free Full Text].
|
| 8.
|
Eckmann, L.,
S. L. Reed,
J. R. Smith, and M. F. Kagnoff.
1995.
Entamoeba histolytica trophozoites induce an inflammatory cytokine response by cultured human cells through the paracrine action of cytolytically released interleukin-1 .
J. Clin. Investig.
96:1269-1279.
|
| 9.
|
Finlay, B. B., and S. Falkow.
1988.
Comparison of the invasion strategies used by Salmonella choleraesuis, Shigella flexneri and Yersinia enterocolitica to enter cultured animal cells: endosome acidification is not required for bacterial invasion or intracellular replication.
Biochimie
70:1089-1099[Medline].
|
| 10.
|
Garcia, L. W.,
R. B. Hemphill,
W. A. Marasco, and P. S. Ciano.
1991.
Acquired immunodeficiency syndrome with disseminated toxoplasmosis presenting as an acute pulmonary and gastrointestinal illness.
Arch. Pathol. Lab. Med.
115:459-463[Medline].
|
| 11.
|
Gazzinelli, R. T.,
S. Hieny,
T. A. Wynn,
S. Wolf, and A. Sher.
1993.
Interleukin 12 is required for the T-lymphocyte-independent induction of interferon by an intracellular parasite and induces resistance in T-cell-deficient hosts.
Proc. Natl. Acad. Sci. USA
90:6115-6119[Abstract/Free Full Text].
|
| 12.
|
Gazzinelli, R.,
Y. Xu,
S. Heny,
A. Cheever, and A. Sher.
1992.
Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii.
J. Immunol.
149:175-180[Abstract].
|
| 13.
|
Hakim, F. T.,
R. T. Gazzinelli,
E. Denkers,
S. Hieny,
G. M. Shearer, and A. Sher.
1991.
CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells.
J. Immunol.
147:2310-2316[Abstract].
|
| 14.
|
Hauser, W. E., and V. Tsai.
1986.
Acute Toxoplasma infection of mice induces spleen NK cells that are cytotoxic for T. gondii in vitro.
J. Immunol.
136:313-319[Abstract].
|
| 15.
|
Hunter, C. A.,
C. S. Subauste,
V. H. Van Cleave, and J. S. Remington.
1994.
Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha.
Infect. Immun.
62:2818-2824[Abstract/Free Full Text].
|
| 16.
|
Jung, H. C.,
L. Eckmann,
S. Yang,
A. Panja,
J. Fierer,
E. Morzycka-Wroblewska, and M. F. Kagnoff.
1995.
A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.
J. Clin. Investig.
95:55-65.
|
| 17.
|
Kahn, I. A.,
T. Matsuura, and L. H. Kasper.
1994.
Interleukin-12 enhances survival against acute toxoplasmosis.
Infect. Immun.
62:1639-1642[Abstract/Free Full Text].
|
| 18.
|
Kasama, T.,
R. M. Strieter,
N. W. Lukacs,
P. M. Lincoln,
M. D. Burdick, and S. L. Kunkel.
1995.
Interferon gamma modulates the expression of neutrophil-derived chemokines.
J. Investig. Med.
43:58-67[Medline].
|
| 19.
|
Khavkin, T.
1981.
Histological and ultrastructural studies of the interaction of Toxoplasma gondii tachyzoites with mouse omentum in experimental infection.
J. Protozool.
28:317-325[Medline].
|
| 20.
|
Kunkel, S. L.,
N. W. Lukacs,
S. W. Chensue, and R. M. Strieter.
1997.
Chemokines and the inflammatory response, p. 121-131.
In
D. G. Remick, and J. S. Friedland (ed.), Cytokines in health and disease. Marcel Dekker, New York, N.Y.
|
| 21.
|
Laurent, F.,
L. Eckmann,
T. C. Savidge,
G. Morgan,
C. Theodos,
M. Naciri, and M. F. Kagnoff.
1997.
Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines.
Infect. Immun.
65:5067-5073[Abstract].
|
| 22.
|
Luster, A. D.
1998.
Chemokines-chemotactic cytokines that mediate inflammation.
N. Engl. J. Med.
338:436-445[Free Full Text].
|
| 23.
|
Mordue, D. G., and L. D. Sibley.
1997.
Intracellular fate of vacuoles containing Toxoplasma gondii is determined at the time of formation and depends on the mechanism of entry.
J. Immunol.
159:4452-4459[Abstract].
|
| 24.
|
Navia, B. A.,
C. K. Petitio,
J. W. M. Gold,
E. S. Cho,
B. D. Jordan, and R. W. Price.
1986.
Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients.
Ann. Neurol.
19:224-238[Medline].
|
| 25.
|
Rasmussen, S. J.,
L. Eckmann,
A. J. Quayle,
L. Shen,
Y. Zhang,
D. J. Anderson,
J. Fierer,
R. S. Stephens, and M. F. Kagnoff.
1997.
Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis.
J. Clin. Investig.
99:77-87[Medline].
|
| 26.
|
Remington, J. S.,
J. L. Krahenbuhl, and J. W. Mendenhall.
1972.
A role for activated macrophages in resistance to infection with Toxoplasma.
Infect. Immun.
6:829-834[Abstract/Free Full Text].
|
| 27.
|
Scharton-Kersten, T. M.,
T. A. Wynn,
E. Y. Denkers,
S. Bala,
E. Grunvald,
S. Hieny,
R. T. Gazzinelli, and A. Sher.
1996.
In the absence of endogenous IFN- , mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.
J. Immunol.
157:4045-4054[Abstract].
|
| 28.
|
Scharton-Kersten, T. M.,
G. Yap,
J. Magram, and A. Sher.
1997.
Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii.
J. Exp. Med.
185:1261-1273[Abstract/Free Full Text].
|
| 29.
|
Subauste, C. S.,
L. Dawson, and J. S. Remington.
1992.
Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii.
J. Exp. Med.
176:1511-1519[Abstract/Free Full Text].
|
| 30.
|
Suzuki, Y.,
M. A. Orellana,
R. D. Schreiber, and J. S. Remington.
1988.
Interferon- : the major mediator of resistance against Toxoplasma gondii.
Science
240:516-518[Abstract/Free Full Text].
|
| 31.
|
Tomee, J. F. C.,
A. T. J. Wierenga,
P. S. Hiemstra, and H. F. Kauffman.
1997.
Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines.
J. Infect. Dis.
176:300-303[Medline].
|
| 32.
|
Wilson, C. B., and J. S. Remington.
1979.
Activity of human blood leukocytes against Toxoplasma gondii.
J. Infect. Dis.
140:890-895[Medline].
|
| 33.
|
Yu, Y., and K. Chadee.
1997.
Entamoeba histolytica stimulates interleukin-8 from human colonic epithelial cells without parasite-enterocyte contact.
Gastroenterology
112:1536-1547[Medline].
|
Infection and Immunity, April 1999, p. 1547-1552, Vol. 67, No. 4
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Tan, K. S. W.
(2008). New Insights on Classification, Identification, and Clinical Relevance of Blastocystis spp.. Clin. Microbiol. Rev.
21: 639-665
[Abstract]
[Full Text]
-
Okomo-Adhiambo, M., Beattie, C., Rink, A.
(2006). cDNA Microarray Analysis of Host-Pathogen Interactions in a Porcine In Vitro Model for Toxoplasma gondii Infection. Infect. Immun.
74: 4254-4265
[Abstract]
[Full Text]
-
Molestina, R. E., Sinai, A. P.
(2005). Host and parasite-derived IKK activities direct distinct temporal phases of NF-{kappa}B activation and target gene expression following Toxoplasma gondii infection. J. Cell Sci.
118: 5785-5796
[Abstract]
[Full Text]
-
Robben, P. M., LaRegina, M., Kuziel, W. A., Sibley, L. D.
(2005). Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis. JEM
201: 1761-1769
[Abstract]
[Full Text]
-
Ryu, J.-S., Kang, J.-H., Jung, S.-Y., Shin, M.-H., Kim, J.-M., Park, H., Min, D.-Y.
(2004). Production of Interleukin-8 by Human Neutrophils Stimulated with Trichomonas vaginalis. Infect. Immun.
72: 1326-1332
[Abstract]
[Full Text]
-
Eickhoff, C. S., Eckmann, L., Hoft, D. F.
(2003). Differential Interleukin-8 and Nitric Oxide Production in Epithelial Cells Induced by Mucosally Invasive and Noninvasive Trypanosoma cruzi Trypomastigotes. Infect. Immun.
71: 5394-5397
[Abstract]
[Full Text]
-
Channon, J. Y., Miselis, K. A., Minns, L. A., Dutta, C., Kasper, L. H.
(2002). Toxoplasma gondii Induces Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor Secretion by Human Fibroblasts: Implications for Neutrophil Apoptosis. Infect. Immun.
70: 6048-6057
[Abstract]
[Full Text]
-
Akkoyunlu, M., Malawista, S. E., Anguita, J., Fikrig, E.
(2001). Exploitation of Interleukin-8-Induced Neutrophil Chemotaxis by the Agent of Human Granulocytic Ehrlichiosis. Infect. Immun.
69: 5577-5588
[Abstract]
[Full Text]
-
Laurent, F., Mancassola, R., Lacroix, S., Menezes, R., Naciri, M.
(2001). Analysis of Chicken Mucosal Immune Response to Eimeria tenella and Eimeria maxima Infection by Quantitative Reverse Transcription-PCR. Infect. Immun.
69: 2527-2534
[Abstract]
[Full Text]
-
Channon, J. Y., Seguin, R. M., Kasper, L. H.
(2000). Differential Infectivity and Division of Toxoplasma gondii in Human Peripheral Blood Leukocytes. Infect. Immun.
68: 4822-4826
[Abstract]
[Full Text]
-
Lu, H., Shen, C., Brunham, R. C.
(2000). Chlamydia trachomatis Infection of Epithelial Cells Induces the Activation of Caspase-1 and Release of Mature IL-18. J. Immunol.
165: 1463-1469
[Abstract]
[Full Text]
-
Blader, I. J., Manger, I. D., Boothroyd, J. C.
(2001). Microarray Analysis Reveals Previously Unknown Changes in Toxoplasma gondii-infected Human Cells. J. Biol. Chem.
276: 24223-24231
[Abstract]
[Full Text]